Zurex Pharma Receives $6,200,000 Series A Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3e091984-7de1-4474-a0cc-92aeb3fea9e4 - Date
5/22/2012 - Company Name
Zurex Pharma - Mailing Address
2113 Eagle Drive Middleton, WI 53562 - Company Description
Zurex Pharma, Inc. is a specialty pharma and medical technology company with a novel antimicrobial technology platform. Our company’s mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare acquired infections with a focus on surgical site wounds and catheter-related infections. - Website
http://www.zurex-pharma.com - Transaction Type
Venture Equity - Transaction Amount
$6,200,000 - Transaction Round
Series A - Proceeds Purposes
Zurex will use the capital to develop and commercialize a portfolio of innovative antimicrobial products designed to prevent healthcare acquired infections with a focus on surgical site wounds and catheter-related infections. - M&A Terms
- Venture Investor
Baird Capital - Venture Investor
Baird Capital - Venture Investor
Wisconsin Investment Partners - Venture Investor
Peak Ridge Capital
